Immunoconjugates as an Efficient Platform for Drug Delivery: A Resurgence of Natural Products in Targeted Antitumor Therapy
The present review provides a detailed and comprehensive discussion on antibody–drug conjugates (ADCs) as an evolving new modality in the current therapeutic landscape of malignant diseases. The principle concepts of targeted delivery of highly toxic agents forsaken as stand-alone drugs are examined...
Saved in:
| Main Authors: | Rositsa Mihaylova, Denitsa Momekova, Viktoria Elincheva, Georgi Momekov |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-12-01
|
| Series: | Pharmaceuticals |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1424-8247/17/12/1701 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of a supramolecular delivery system based on hyaluronic acid with cyclodextrin on the antitumor properties of oxaliplatin <i>in vitro</i>
by: E. A. Pashkina, et al.
Published: (2024-09-01) -
The antitumor mechanisms of glabridin and drug delivery strategies for enhancing its bioavailability
by: Chong Li, et al.
Published: (2024-12-01) -
Efficacy of Anti-Cancer Immune Responses Elicited Using Tumor-Targeted IL-2 Cytokine and Its Derivatives in Combined Preclinical Therapies
by: Sahar Balkhi, et al.
Published: (2025-01-01) -
Palbociclib as an Antitumor Drug: A License to Kill
by: Agnieszka Łupicka-Słowik, et al.
Published: (2024-11-01) -
Engineered probiotic-mediated intratumoral delivery and controlled release of bacterial collagenase for cancer therapy
by: Hong-Rui Li, et al.
Published: (2025-03-01)